|
⚲
|
| Avoro Capital Advisors LLC
✚
| |
|---|---|
| CRD # | 154091 |
| SEC # | 801-74391 |
| CIK # | 0001633313 |
| AUM | $8.7 BB (2024-06-04) |
| Employees | 15 (67% Investors, 0% Brokers) |
| Phone | 212-937-4970 |
| Address | 110 Greene Street New York, NY 10012 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($BB) |
|---|
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| UTHR | 10.6 | 0.9 | |
| MDGL | 1.2 | 0.6 | |
| ASND | 5.2 | 0.6 | |
| ARGX | 19.8 | 0.5 | |
| SRPT | 6.5 | 0.5 | |
| KRYS | 1.7 | 0.4 | |
| APLS | 4.7 | 0.4 | |
| BMRN | 15.4 | 0.4 | |
| FOLD | 3.0 | 0.3 | |
| RNA | 0.7 | 0.3 | |
| View All | |||
| Holdings by Sector ($BB) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| VC | Avoro Ventures Fund LP | [2021-03-23] | 178.4 | 165.8 |
| VC | venBio Global Strategic Fund II LP | [2016-03-29] | 337.0 | 315.2 |
| HF | Avoro Life Sciences Fund LLC | [2012-02-22] | 1,996.9 | 8,572.1 |
| VC | venBio Global Strategic Fund LP | [2012-02-22] | 177.0 | 178.8 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 8.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 8.7 |
| By Discretionary | ||
| Discretionary | 3 | 8.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 8.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 4.3 | |
| United States Persons | 4.4 | |
| Total | 3 | 8.7 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 | |
|---|---|---|---|---|
| Corey Goodman | 37 | |||
| Robert Adelman | 23 | |||
| Kurt von Emster | 19 | |||
| Paul Brooke | 9 | |||
| Behzad Aghazadeh | 5 | |||
| Scott Epstein | 4 | |||
| Avoro Capital GP LLC | 3 | |||
| Avoro Capital LP | 3 | |||
| Avoro Capital Advisors LLC | 2 | |||
| venBio Select Advisor | 2 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001633313] | |
| 3 | [0001633313] | |
| 4 | [0001633313] | |
| SC 13D | [0001633313] | |
| SC 13G | [0001633313] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| Avoro Capital Advisors LLC | |
| Avoro Ventures LLC | |
| Aadi Bioscience, Inc. | |
| Aghazadeh Behzad | |
| CymaBay Therapeutics, Inc. | |
| Immunomedics Inc | |
| Mirati Therapeutics, Inc. |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Eagle Point Credit Management LLC
✚
|
CT | 9.3 |
|
HG VORA Capital Management LLC
✚
|
NY | 9.3 |
|
RTW Investments LP
✚
|
NY | 8.8 |
|
Maverick Capital Ltd
✚
|
TX | 8.8 |
|
First Sentier Investors Australia RE Ltd
✚
|
8.7 | |
|
Corsair Capital LLC
✚
|
NY | 8.4 |
|
Christofferson Robb & Company LLC
✚
|
NY | 8.1 |
|
ORIX Advisers LLC
✚
|
NY | 8.1 |
|
Darsana Capital Partners LP
✚
|
NY | 8.1 |
|
Magnitude Capital LLC
✚
|
NY | 8.0 |